Cystic fibrosis physicians’ perspectives on the timing of referral for lung transplant evaluation: a survey of physicians in the United States

Table 4 Comorbidities that would prevent referral for lung transplant evaluation, grouped by Program type

	All Respondents^a N = 114	Adult Programs N = 57	Affiliate Programs N = 12	Pediatric Programs N = 43
	n (%)	n (%)	n (%)	n (%)
Tissue diagnosis of cancer	74 (65%)	39 (68%)	9 (75%)	26 (61%)
CF-related ESRD requiring dialysis	50 (44%)	23 (40%)	6 (50%)	21 (49%)
Inadequate nutritional status (e.g. BMI <18)	33 (29%)	18 (32%)	4 (33%)	9 (21%)
CF-related liver cirrhosis	18 (16%)	13 (23%)	0	5 (12%)
CF-related diabetes, poorly controlled	18 (16%)	11 (19%)	2 (17%)	5 (12%)
Depression, anxiety	10 (9%)	3 (5%)	1 (8%)	6 (14%)
Pulmonary hypertension	1 (1%)	0	1 (8%)	0
Osteoporosis	1 (1%)	1 (2%)	0	0
CF-related sinus disease, extensive	0	0	0	0
Gastro-esophageal reflux disease	0	0	0	0
Other (free text response)	31 (27%)	19 (33%)	3 (25%)	9 (21%)
Skipped question^b	12 (11%)	5 (9%)	0	7 (16%)

CF cystic fibrosis, ESRD end-stage renal disease, BMI body mass index
^aTwo respondents did not report Program type
^bAssumption: none of these would prevent referral for lung transplant evaluation

ISSN: 1471-2466